U.S. federal trademark · Serial No. 87901403 · Reg. No. 017889585
Development of pharmaceutical substances for treatment and easement of Alzheimer's disease, only for human use; Scientific and technological services, namely, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical drug development services, pharmaceutical product evaluation and pharmaceutical research and development; scientific research and design, namely, scientific research in the field of pharmaceuticals; Research in relation to pharmaceuticals; Research and development of vaccines and medicines; Conducting early stage evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Drug discovery services; Technical data analysis services, namely, data analysis through data mining; Computer-supported technical analysis services, namely, chemical analysis, and data analysis through data mining
Pharmaceutical, veterinary and medical preparations for treating Alzheimer's, cognitive disorders, traumatic brain injury, sleep apnea and Parkinson's disease; Pharmaceutical substances for treatment and easement of Alzheimer's disease, only for human use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.